Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine4,6-dicarboxylic acid diamides for selective collagenase inhibition

Details for Australian Patent Application No. 2002358535 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Kirsch, Reinhard; Weithmann, KlausUlrich; Kogler, Herbert; Habermann, Jorg; Wehner, Volkmar

Agent Watermark

Pub. Number AU-B-2002358535

PCT Number PCT/EP02/13240

PCT Pub. Number WO2003/049738

Priority 101 60 357.6 08.12.01 DE

Filing date 25 November 2002

Wipo publication date 23 June 2003

Acceptance publication date 10 May 2007

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/28 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 101 60 357.6 08.12.01 DE

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002358535

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

10 May 2007 Application Accepted

  Published as AU-B-2002358535

6 September 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002358536-ORGANIC FLUORESCENT LABEL WITH MULTIPLEXING CAPABILITIES FOR BIOLOGICAL APPLICATIONS

2002358534-SUBSTITUTED PHENYL DERIVATIVES